| Literature DB >> 27529221 |
Faiza Rao1,2, Yiwen Zhai3,4, Fei Sun5.
Abstract
Punicalagin (PU) is a known antioxidant. The present study examined PU to protect against lead-induced oxidative stress (OS) testicular damage in mice. Significant increase in lipid peroxidation (LPO) after intraperitoneal injection of lead acetate (LA) indicated enormous generation of reactive oxygen species (ROS). Lead-induced OS has a direct effect on the differentiation of spermatogonial cells, showing a significant decline in sperm count. Supplementation of PU significantly changes values of LPO and glutathione (GSH) with a concomitant increase in sperm count, a marked decrease in the abnormal sperms, and a decline in the morphologically abnormal sperm population. Moreover, the histopathological evaluation of testes and epididymides showed severe changes in mice treated with LA. PU significantly induced nuclear factor erythroid-2 related factor 2-like 2 (Nrf2) expression and phase II enzymes, and data suggest that PU may inhibit OS through Nrf2 activation. The fertility test proved that PU might play an important role in male infertility treatment, especially in the type of infertility induced by OS.Entities:
Keywords: fertility; lead acetate; oxidative stress; punicalagin; testicular damage
Mesh:
Substances:
Year: 2016 PMID: 27529221 PMCID: PMC5000667 DOI: 10.3390/ijms17081269
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Effect of punicalagin (PU) on lipid peroxidation (LPO), glutathione GSH, 8-hydroxy-2′-deoxyguanosine (8-OHdG), superoxide dismutase (SOD) and catalase (CAT) in lead acetate (LA)- intoxicated mice testis (mean ± standard deviation (SD)).
| LPO (µmol/g Prot) | GSH (mg/g Prot) | 8-OHdG (ng/mL Tissue Homogenate) | SOD (U/mg Prot) | CAT (nmol/mg Prot) | |
|---|---|---|---|---|---|
| Control | 1.93 ± 0.10 | 26.38 ± 0.90 | 1.16 ± 0.17 | 49.83 ± 0.98 | 72.91 ± 0.49 |
| PU | 1.95 ± 0.09 | 26.23 ± 0.96 | 1.18 ± 0.17 | 49.97 ± 1.17 | 72.97 ± 0.48 |
| LA | 10.45 ± 0.48 | 12.12 ± 1.38 | 6.70 ± 0.36 | 34.79 ± 0.52 | 52.83 ± 0.64 |
| PU + LA | 3.85 ± 0.35 | 22.14 ± 1.36 | 2.39 ± 0.32 | 47.92 ± 0.74 | 67.90 ± 0.49 |
Figure 1Testes histology. (A,B) Regular-shaped and normal spermatogenesis observed in control and punicalagin (PU)-injected mice testes; (C) Co-injection of PU and lead acetate (LA) protected testes against oxidative injury; normal seminiferous tubules with presence of sperm and less degenerative germ cells could be observed; (D) An amount of 100 mg/kg of LA administered intraperitoneally in mice; a single dose causes oxidative stress–induced damage in mice testes. The figure shows degeneration of germ cells, absence of sperm and vacuolation formation in testicular tissue; (E) Degeneration of seminiferous epithelium, vacuolization (arrow in figure), disordered epithelium and loss of sperms were evidenced in LA-treated group.
Figure 2Epididymis histology. (A,B) Control and PU groups show maximum number of sperms in epididymis; (C) LA-induced OS proved damage to sperms as the epididymis shows reduction of sperm count; (D) PU + LA co-administration presented increase in number of sperms in epididymis.
Figure 3Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activation. (A) Real time reverse transcript-PCR was performed to detect expression of Nrf2 and its target genes heme oxygenase-1 (HO-1) and glutamyl-cysteine ligase (GCL); (B) Western blot analysis results show Nrf2 and HO-1 increase in LA + PU. (*, #, † p < 0.0001 values compared for two groups).
Figure 4Sperm morphology. (A,E) Normal sperm, pointed out by arrow showing acrosome formation as dark black color on sperm head; (B) abnormal sperm with bent head; (C) abnormal sperm with twisted head and neck; (D) abnormal sperm morphology with head damage and coiled tail; (F) arrow head showing abnormal formation of acrosome.
LA effect on testes weight grams (g), sperm abnormality (per 1000 sperm), blood lead level (µg/mL), sperm count (×106). All results shown as mean ± standard error (SE).
| Group 1 (Control) | Group 2 (PU) | Group 3 (LA) | Group 4 (LA+ PU) | |
|---|---|---|---|---|
| Blood lead level | 0.17 ± 0.014 | 0.168 ± 0.01 | 0.426 ± 0.035 * | 0.20 ± 0.022 |
| Abnormal sperm | 112.5 ± 1.85 | 112.3 ± 1.40 | 209 ± 4.4 * | 125 ± 4.9 |
| Testes weight | 0.22 ± 0.02 | 0.216 ± 0.01 | 0.14 ± 0.01 * | 0.198 ± 0.01 |
| Sperm count | 24 ± 1.03 | 23 ± 1.1 | 14.9 ± 0.9 * | 20.6 ± 1.03 |
* p < 0.0001 as compared group 3 with group 1 and group 4.
Mating test (mean ± SD).
| Control | PU | LA | PU + LA | |
|---|---|---|---|---|
| No. of females pregnant | 2 ± 0 | 2 ± 0 | 1.6 ± 1.03 * | 2 ± 0 |
| No. of pups | 12 ± 0.92 | 12.2 ± 1.16 | 5.12 ± 4.45 * | 10.25 ± 1.16 |
* p < 0.0001 as compared between control, LA, PU + LA groups.